Sacituzumab govitecan (IMMU-132) for patients with pretreated metastatic urothelial uancer (UC): interim results

Autor:	Alicia K. Morgans, David M. Goldenberg, Elaine T. Lam, Scott T. Tagawa, Kevin Kalinsky, Daniel P. Petrylak, William A. Wegener, Julio Hajdenberg, Philip J. Saylor, Matthew D. Galsky, Bishoy Faltas, Aditya Bardia, Emerson A. Lim, B. Mudenda, P. Maliakal, Robert M. Sharkey, Michael J. Guarino
Rok vydání:	2017
Předmět:	Oncology 03 medical and health sciences medicine.medical_specialty 0302 clinical medicine business.industry 030220 oncology & carcinogenesis Internal medicine Interim 030232 urology & nephrology medicine Hematology business
Zdroj:	Annals of Oncology. 28:v301-v302
ISSN:	0923-7534
DOI:	10.1093/annonc/mdx371.012
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3d001c3ae7dc4a5957928f68a2e69cbe https://doi.org/10.1093/annonc/mdx371.012 Zobrazit plný text záznamu